Pathogenetic treatment of influenza patients with aerosolized form of aprotinin, a protease inhibitor

Therapeutic and antiviral efficacies of inhalations of aerosolized aprotinin, a protease inhibitor, which blocks a stage of influenza virus proteolytic activation, were studied. This clinical study was performed during winter-spring outbreak caused with pandemic Influenza H1N1pdm09. Aprotinin (a nat...

Cijeli opis

Bibliografski detalji

Glavni autori:	O. P. Zhirnov, N. O. Bokova, E. I. Isaeva, I. V. Vorobieva, N. A. Malyshev
Format:	Artigo
Jezik:	Russo
Izdano:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Serija:	Биопрепараты: Профилактика, диагностика, лечение
Teme:	influenza pathogenesis aprotinin chemotherapeutic compound therapy proteolytic activation грипп патогенез апротинин химиопрепарат лечение протеолитическая активация
Online pristup:	https://www.biopreparations.ru/jour/article/view/35
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!